| Primary |
| Hepatic Cirrhosis |
30.9% |
| Hepatitis B |
25.3% |
| Drug Use For Unknown Indication |
15.4% |
| Hypertension |
3.5% |
| Hepatectomy |
3.4% |
| Gastritis |
2.7% |
| Gastric Ulcer |
2.3% |
| Constipation |
2.0% |
| Ascites |
1.6% |
| Osteoporosis |
1.6% |
| Antiviral Prophylaxis |
1.4% |
| Insomnia |
1.4% |
| Diabetes Mellitus |
1.2% |
| Hepatitis |
1.2% |
| Gastroenteritis |
1.0% |
| Neuropathy Peripheral |
1.0% |
| Prophylaxis |
1.0% |
| Viral Hepatitis Carrier |
1.0% |
| Asthma |
0.9% |
| Bronchitis |
0.9% |
|
| Hepatic Neoplasm Malignant |
19.5% |
| White Blood Cell Count Decreased |
7.5% |
| Platelet Count Decreased |
6.9% |
| Hepatic Function Abnormal |
5.7% |
| Liver Disorder |
5.0% |
| Thrombocytopenia |
5.0% |
| Oesophageal Varices Haemorrhage |
4.4% |
| Red Blood Cell Count Decreased |
4.4% |
| White Blood Cell Count Increased |
4.4% |
| Drug Exposure During Pregnancy |
3.8% |
| Hepatitis B |
3.8% |
| Pneumocystis Jiroveci Pneumonia |
3.8% |
| Thyroid Function Test Abnormal |
3.8% |
| Urticaria |
3.8% |
| Macroamylasaemia |
3.1% |
| Pyrexia |
3.1% |
| Renal Impairment |
3.1% |
| Renal Tubular Disorder |
3.1% |
| Transmission Of Drug Via Semen |
3.1% |
| Confusional State |
2.5% |
|
| Secondary |
| Hepatic Cirrhosis |
32.8% |
| Hepatitis B |
24.4% |
| Product Used For Unknown Indication |
7.2% |
| Hepatectomy |
5.5% |
| Chronic Hepatitis B |
4.8% |
| Drug Use For Unknown Indication |
3.6% |
| Lymphoma |
3.4% |
| Chronic Hepatitis |
2.9% |
| Hiv Infection |
2.1% |
| Gastritis |
1.9% |
| Ascites |
1.7% |
| Liver Disorder |
1.5% |
| Acquired Immunodeficiency Syndrome |
1.3% |
| Amyotrophic Lateral Sclerosis |
1.3% |
| B-cell Lymphoma |
1.1% |
| Hepatic Neoplasm Malignant |
1.1% |
| Hypertension |
1.1% |
| Gastroenteritis |
0.8% |
| Hyperuricaemia |
0.8% |
| Rash |
0.8% |
|
| Hepatic Neoplasm Malignant |
25.9% |
| Renal Impairment |
7.4% |
| Macroamylasaemia |
6.5% |
| Oesophageal Varices Haemorrhage |
5.6% |
| Hyperlactacidaemia |
4.6% |
| Osteomalacia |
4.6% |
| Thyroid Function Test Abnormal |
4.6% |
| Transmission Of Drug Via Semen |
4.6% |
| Urticaria |
4.6% |
| Transaminases Increased |
3.7% |
| Upper Respiratory Tract Inflammation |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
| Drug Exposure During Pregnancy |
2.8% |
| Hyperlipidaemia |
2.8% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
2.8% |
| Renal Disorder |
2.8% |
| Renal Tubular Disorder |
2.8% |
| Varices Oesophageal |
2.8% |
| Anaemia |
1.9% |
| Blood Alkaline Phosphatase Increased |
1.9% |
|
| Concomitant |
| Hepatitis B |
19.7% |
| Hepatic Cirrhosis |
13.0% |
| Product Used For Unknown Indication |
7.9% |
| Insomnia |
7.5% |
| Depression |
5.2% |
| Chronic Hepatitis B |
5.0% |
| Gastritis |
5.0% |
| Hepatic Neoplasm Malignant |
4.2% |
| Pneumonia |
4.2% |
| Head And Neck Cancer |
3.3% |
| Constipation |
2.9% |
| Drug Use For Unknown Indication |
2.9% |
| Malignant Peritoneal Neoplasm |
2.9% |
| B-cell Lymphoma |
2.7% |
| Osteoporosis |
2.7% |
| Multiple Myeloma |
2.5% |
| Prophylaxis |
2.5% |
| Deep Vein Thrombosis |
2.1% |
| Gastric Ulcer |
1.9% |
| Benign Prostatic Hyperplasia |
1.7% |
|
| Osteomalacia |
9.8% |
| Renal Disorder |
7.6% |
| Hepatitis Fulminant |
6.5% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
6.5% |
| Platelet Count Decreased |
6.5% |
| Pyrexia |
5.4% |
| Renal Failure |
5.4% |
| Diverticular Perforation |
4.3% |
| Hepatic Function Abnormal |
4.3% |
| Hepatitis B |
4.3% |
| Liver Disorder |
4.3% |
| Pathogen Resistance |
4.3% |
| Renal Impairment |
4.3% |
| Tubulointerstitial Nephritis |
4.3% |
| Ulcer |
4.3% |
| Urine Uric Acid Increased |
4.3% |
| Fanconi Syndrome Acquired |
3.3% |
| Renal Failure Acute |
3.3% |
| Weight Decreased |
3.3% |
| White Blood Cell Count Decreased |
3.3% |
|
